GlassScriptPhysician profile
Roger B Nowak
NPI 1417904343
$5,290.63
in general payments reported to CMS, 2019-2025
18 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $442 · 2021: $715 · 2022: $1,946 · 2023: $656 · 2024: $127 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,681.01 | 2019-2025 | Iovera, Exparel, Zilretta |
| Kairos Surgical INC | $1,436.59 | 2022-2023 | |
| Pacira Therapeutics, INC. | $537.50 | 2019-2021 | |
| Trice Medical, INC. | $304.35 | 2019 | |
| Endo USA, INC. | $208.48 | 2024-2025 | Xiaflex |
| Ortho Development Corporation | $189.29 | 2023 | |
| Depuy Synthes Sales INC. | $162.86 | 2021-2024 | Monovisc, Orthovisc |
| Siemens Medical Solutions USA, INC. | $150.50 | 2022 | |
| Anika Therapeutics, INC. | $147.67 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $90.81 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $82.51 | 2023-2024 | Xiaflex |
| Smith+Nephew, INC. | $75.85 | 2020 | |
| Djo, LLC | $53.70 | 2019 | |
| Orthofix Medical, INC. | $47.65 | 2021-2024 | Accelstim, Physio-Stim |
| Fidia Pharma USA INC. | $46.18 | 2022-2025 | Hymovis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $42.99 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $16.41 | 2023 | Euflexxa |
| Convatec INC. | $16.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Nowak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.